In the European research project, CREDOS (Crosswind-Reduced Separations for Departure Operations), the feasibility of a concept for reduced wake turbulence separations upon departure in crosswind conditions has been investigated. The safety assessment of this concept includes risk assessment with respect to wake vortex encounters. This paper describes the methodology developed for this assessment and its application during the project. The methodology employs two simulation tools, the Wake Vortex Scenarios Simulation Package for Departure (WakeScene-D) and the Vortex Encounter Severity Assessment for Departure (VESA-D), which are extensions of existing tools related to the departure flight phase. WakeScene-D primarily determines the frequency of wake encounters, whereas VESA-D estimates the severity of these encounters. Both can be combined to quantify and compare wake encounter risk for various departure scenarios. In the risk assessment, departures with variable aircraft separations and varying crosswind conditions were investigated to determine which crosswind level is necessary to suspend wake-turbulence-related separations during departure without degrading safety. Monte Carlo simulations have been conducted comparing medium and heavy aircraft type departures with 2 min. of separation to departures with a separation of 1 min. under varying crosswind strengths. The results not only give an indication of which crosswind magnitudes could be sufficient to safely suspend wake-turbulence-related separations upon takeoff, but they also reveal significant influences, such as the departure route layout and the change of wind direction with altitude, on wake encounter risk.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.